Stephen Brannan, VP at Takeda to speak at 2nd CNS Diseases World Summit Sept 13-14 San Francisco
FOR IMMEDIATE RELEASE / PRURGENT
Stephen Brannan, Vice President and Therapeutic Area Leader for Neuroscience, Clinical Science at Takeda Global Research & Development [TGRD] will give a plenary keynote presentation at the 2nd CNS Diseases World Summit taking place on Sept 13-14, 2012 in San Francisco, CA.
Dr. Brannan became Vice President and Therapeutic Area Leader for Neuroscience, Clincal Development of Takeda in May 2011. Prior to that, he served as the Executive Medical Director of Takeda, Senior Medical Director at Novartis, and as Senior Medical Director at Cyberonics. Dr. Brannan was also an Assistant Professor at UTHSCSA
GTC's 2nd CNS Diseases World Summit brings together the leading experts across the industry and academia to discuss the latest research and developments in the CNS field. The summit has four parallel tracks that focus on neurodegenerative conditions, neuropsychiatric disorders, pain research and therapeutics and CNS partneriing and deal-making.
Network with colleagues at this CNS summit and hear from key representatives in the field including Charles B. Nemeroff at University of Miami, Husseini Manji - Global Head of Neuroscience Therapeutic at Janssen, Barry Brand - Chief Executive Officer at CeNeRx, Michael W. Weiner at UCSF, George Garibaldi - Global Head of CNS Clinical Development at F. Hoffmann-La Roche, Tony W. Ho - Vice President at AstraZeneca, and many more!
For more information, please visit www.gtcbio.com | 
